From the start of 2025, we’re now offering a pricing structure on a combined purchase of Cingal and Monovisc. Our basic list pricing throughout 2025 will remain the same for a third year running, which is since we started managing the portfolio in the UK.
We do get asked a lot about discounts on Cingal. Back in 2022, the UK price was actually over £200! We addressed this straight away and remain at the lowest price possible for single purchases or bulk buys.
You’ll notice from the image above we’ve introduced an incentive for those amazingly wonderful customers who order both Cingal and Monovisc. While we appreciate you can’t always balance the amount of Cingal and Monovisc you need equally, we hope this supports you from time to time.
– This offer is exclusive to independent private clinics.
Visit our online order form here
For the combined ordering of Cingal and Monovisc, the £365 price reflects an offer that for every 2 Cingal and 2 Monovisc ordered, one of those Monovisc is essentailly free of charge – Across the average of 4 injections this is £91.25 per injection.
Value
Innovation and pushing treatment options forward is important, we’re 100% behind new technologies coming through and it’s fantastic for patients. However, in a world where new products hit the shelves with lesser data, costing patients £1000’s, we firmly believe Cingal represents the best value OA injection therapy available anywhere in the world, which is critical in a self paying market and powerful to be able to offer as an option.
The 92% responder index and 72% WOMAC pain reduction is unmatched for results and quality of data. STUDY REF HERE
Monovisc is a multi-joint option. It can be used for Ankle, Knee, Hip and Shoulder joint OA. In a 4ml single injection, Monovisc introduces 88mg of ultra-pure HA into the joint space. The molecular weight of the HA targets endogenous HA production. It is also lightly and optimally crosslinked, unlike many other options. This enhances residency time in the joint. A next generation of pure HA when compared to non-crosslinked single injections that may require more frequent ‘top-ups’. Monovisc is the most used HA worldwide with over 3 million injections now used. Within the new package deal, £52.50 is true value.
Learn more about Monovisc here
If you’d like to know more about Cingal, Monovisc or our growing number of patient educational support pieces, don’t hesitate to reach out to us